logo

For the Inventor, By the Inventor

New York, NY, United States of America

Mink Therapeutics, Inc.


USPTO Granted Patents = 4


Forward Citations = 1

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Mark A Exley (3 out of 14 patents)

silverMedal Marc A Van Dijk (3 out of 42 patents)

bronzeMedal Benjamin Jacob Wolf (3 out of 3 patents)

4.  Arthur Andrew Hurwitz (3 out of 3 patents)

5.  Sébastien Lalevée (3 out of 3 patents)

6.  Volker Seibert (2 out of 14 patents)

7.  Ekaterina Vladimirovna Breous-Nystrom (2 out of 14 patents)

8.  Alessandra Franchino (2 out of 2 patents)

9.  Cornelia Anne Mundt (1 out of 19 patents)

10.  Reed Masakayan (1 out of 1 patent)

11.  Daniel Leventhal (1 out of 1 patent)

12.  Robert Benjamin Stein (1 out of 1 patent)

13.  Marc Van Dijk (1 out of 1 patent)

14.  Mark Adrian Exley (0 patent)


4 patents:

1. 12391741 - T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof (2025-08-19),
2. 11898165 - Engineered host cells and methods of use thereof (2024-02-13),
3. 11718658 - T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof (2023-08-08),
4. 11613764 - T cell receptors that bind to NY-ESO-1 and methods of use thereof (2023-03-28),
logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#1,306 in New York, NY

#3,528 in New York

#59,049 in US

...
New York, NY, United States of America

Mink Therapeutics, Inc.

Forward Citations = 1

13 inventors:

goldMedal Mark A Exley (3 out of 14 patents)

silverMedal Marc A Van Dijk (3 out of 42 patents)

bronzeMedal Benjamin Jacob Wolf (3 out of 3 patents)

4.  Arthur Andrew Hurwitz (3 out of 3 patents)

5.  Sébastien Lalevée (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com
Loading…